HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION Russian patent published in 2011 - IPC A61K38/43 A61K41/00 A61K47/48 A61P7/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to pharmacology and haematology. A hemostimulant represents hyaluronidase immobilised on low-molecular polyethylene glycol of molecular weight 400 to 4000 Da by directed accelerated electron flow 2.5 MeV with absorbed dose 2 to 10 kGy and dose setup rate 1.65 kGy/hour. For hemopoiesis stimulation, hyaluronidase immobilised as stated above is introduced either parenterally, or orally 1 time a day for 1-5 days in dose 10-1000 Unit/kg.

EFFECT: use of hyaluronidase immobilised with using an electron-beam synthesis technology enables higher safety and efficiency of hemopoiesis stimulation.

2 cl, 3 tbl, 1 ex